澳门大阳城122.ccapp官方下载

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Exome sequencing identifies a novel missense mutation of WFS1 as the cause of non-syndromic low-frequency hearing loss in a Chinese family.

Int J Pediatr Otorhinolaryngol.. 2017-09; 
Niu Z,Feng Y,Hu Z,Li J,Sun J,Chen H,He C,Wang X,Jiang L,Liu Y,Cai X,Wang L,Cai Y,Liu X,Mei L.
Products/Services Used Details Operation
Gene Synthesis ... Sanger sequencing was used for co-segregating analysis on all of the candidate variants in this family. Primers flanking the candidate loci were designed using Primer 5 (Premier, Palo Alto, CA) and synthesized by Genscript, Nanjing, China (Supplementary Table S1 online). ... Get A Quote

摘要

OBJECTIVE: Autosomal dominant non-syndromic low-frequency sensorineural hearing loss (LFSNHL) DFNA6/14/38 is an uncommon type of hearing loss that classically affects low frequencies of 2000 Hz and below, demonstrating an ascending configuration. The current study aimed to investigate the cause of LFSNHL in a five-generation Chinese family. METHODS: The phenotype of the Chinese family was characterized using audiologic testing and pedigree analysis. The combined approach of array screening and whole-exome sequencing was used to identify the disease-causing gene in this family. RESULTS: This pedigree, in which the affected subjects presented isolated low-frequency sensorineural hearing impairment with childho... More

关键词

DFNA6/14/38; Exome sequencing; Low-frequency hearing loss; Novel mutation; WFS1